跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,783 条关于
“HAYA Therapeutics”
全部
16,783
临床试验
3,710
药物
3,120
机构
1,135
资讯
8,818
3个月前
HAYA Therapeutics Doses First Patients in Phase 1 Trial of HTX-001 for Cardiac Fibrosis
去年
HAYA Therapeutics Secures $65 Million Series A to Advance RNA-Guided Medicines Targeting the "Dark Genome"
去年
Haya Therapeutics Secures $65M to Develop Drugs Targeting the 'Dark Genome'
去年
Viva Biotech Portfolio Companies Achieve Clinical Milestones in Diabetes, Gout, Obesity, Cancer, and Stroke
10个月前
Rubedo Life Sciences Partners with SVAX to Advance Anti-Aging Drug RLS-1496 in Middle East Phase 2 Trials
去年
Osimertinib Recommended for EU Approval in Unresectable EGFR-Mutated NSCLC
去年
CHMP Recommends Tagrisso for Unresectable EGFR-Mutated Lung Cancer in the EU
去年
Osimertinib Recommended for EU Approval in Locally Advanced EGFR-Mutated NSCLC After Chemoradiation
去年
Tagrisso Approved in EU for Unresectable EGFR-Mutated Non-Small Cell Lung Cancer
8个月前
Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics to Advance RNA-LNP Therapeutics
第 1 页,共 882 页
上一页
下一页